Economic consequences of epidemiological changes in diabetes in middle-income countries: The Mexican case

Diabetes Care

Volumn 27, Issue 1, 2004, Pages 104-109

  Arredondo, Armando ^a   Zúñiga, Alexis ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DEVELOPING COUNTRY; DIABETES MELLITUS; ECONOMIC ASPECT; EVALUATION; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE SYSTEM; HEALTH SERVICE; HUMAN; MEXICO; MIDDLE INCOME COUNTRY;

COSTS AND COST ANALYSIS; DIABETES MELLITUS; HUMANS; INCOME; MEXICAN AMERICANS; MEXICO; TIME FACTORS;

EID: 1042291847     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.1.104     Document Type: Article

References (27)

1. World Health Organization: What resources are needed. In World Health Report 2000, Health Systems: Improving Performance. Geneva, World Health Org., 2000, p. 73-77
2. Sassi F, Archard L, Le Grand J: Economic Evaluation of Health Care: Research Questions. London, London School of Economics and Political Science, 2001, p. 35-46
3. Barcelo A, Aedo C, Rajpathak S, Robles S: The cost of diabetes in Latin America and the Caribbean. Bull World Health Organ 81:19-27, 2003
4. Nichols GA, Glauber HS, Brown JB: Type 2 diabetes: incremental medical care costs during the 8 years preceding diagnosis. Diabetes Care 23:1654-1659, 2000
5. Hogan P, Dall T, Nikolov P, American Diabetes Association: Economic costs of diabetes in the U.S. in 2002. Diabetes Care 26:917-932, 2003
6. Arredondo A: Costs and financial consequences of México's epidemiologic profile change: information for policy makers. Health Policy 42:39-48, 1997
7. Barcelo A, Daroca MC, Ribera R, Duarte E, Zapata A, Vohra M: Diabetes in Bolivia. Rev Panam Salud Publica 10:318-323, 2001
8. Brown JB, Pedula KL, Bakst AW: The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med 159:1873-1880, 1999
9. International Diabetes Federation: Direct Cost to the Health Care Sector. Brussels, Belgium, International Diabetes Federation, México D.F., México, Diabetes Health Economics 1999, p. 13-15
10. Frenk J, Zuita B, Franco F, Arredondo A, Quisser M, Ramírez R: Demanda y Oferta de Servicios Médicos: Obstáculos a la Mejoría del Sistema de Salud en México. Fundación Mexcana Para la Salud Ed, México D.F., México, 1994, p. 23-46
11. Secretaría de Salud: Información básica sobre recursos y servicios del Sistema Nacional de Salud. Salud Pub Mexico 42:68-76, 2003
12. Arredondo A, Damian T: Economic costs for the production of health services: from the cost of inputs to the cost of case-management. Salud Pub Mexico 39:117-126, 1997
13. Olivera E, Duhalde E, Gagliardino JJ: Cost of temporary and permanent disability induced by diabetes. Diabetes Care 14:593-596, 1999
14. SSA: Información básica sobre recursos y servicios del Sistema Nacional de Salud. Salud Pub Mexico 42:68-76, 2003
15. SSA, IMSS, ISSSTE: Boletín de Información Estadística. Casos de Morbilidad Hospitalaria por Demanda Específica, 1993-2002. Secretaría de Salad Ed, México D.F., México, 2003, p. 2-7
16. Murray A: Statistical modelling and statistical inference: measurement error in the explanatory variables: Box-Jenkins technique. In Statistical Modelling in GLIM. New York, Oxford University Press, 1990, p. 67-112
17. Eastman RC, Javitt JC, Herman WH, Dasbach EJ, Zbrozek AS, Dong F, Manninen D, Garfield SA, Copley-Merriman C, Maier W, Eastman JF, Kotsanos J, Cowie CC, Harris M: Model of complications of NIDDM, I. Model construction and assumptions. Diabetes Care 20:725-734, 1997
18. Banco de México: Indice Nacional de Precios por Servicios Médicos en México: Cuadernos Mensuales, Base 1980=100: la Actividad Económica en México: 1983-2002. México D.F., México, Gerencia de Investigación Económica, 2003, p. 35-68
19. Juárez C, Arredondo A: La Regulación del Mercado de Servicios de Salud. Un Análisis Desde la Perspectiva de Equidad y Ética. Centro Interamericano de Estudios en Seguridad Social. Documento de Trabajo. Iguazu, Brazil, Jornadas Internacionales en Economía de la Salud, 2003, p. 13-16
20. Phillips M, Salmerón J: Diabetes in Mexico: a serious and growing problem. World Health Stat Q 45:338-346, 1992
21. Secretaría de Salud: Catálogo de Beneficios Médicos del Seguro Popular de Salud. México D.F., México, 2002, p. 17-31.
22. SSA, IMSS, ISSSTE: Programa Nacional de Salud 2001-2006: la Democratización de la Salud en México: Hacia un Sistema Universal de Salud. México D.F., México, 2001, p. 15-49
23. International Diabetes Federation: Diabetes Health Economics: Facts, Figures and Forecasts: IDF Task Force on Health Economics. Brussels, Belgium, International Diabetes Federation, 1999, p. 7-12 and 24-27
24. Huse DM, Oster G, Killen AR, Lacey MJ, Colditz GA: The economic costs of non-insulin-dependent diabetes mellitus. JAMA 262:2708-2713, 1989
25. Herman WH, Eastman RC: The effects of treatment on the direct cost of diabetes. Diabetes Care 21:19-24, 1998
26. American Diabetes Association: Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 21:296-309, 1998
27. Dawson KG, Gomes D, Gerstein H, Blanchard JF, Kahler KH: The economic cost of diabetes in Canada, 1998. Diabetes Care 25:1303-1307, 2002